Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

Diabetes Care. 2012 Jun;35(6):1279-84. doi: 10.2337/dc11-1277. Epub 2012 Apr 17.

PMID:
22511257
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD.

Lancet. 2010 Feb 6;375(9713):481-9. doi: 10.1016/S0140-6736(09)61969-3. Epub 2010 Jan 26.

PMID:
20110121
[PubMed - indexed for MEDLINE]
3.

Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

Yurgin N, Secnik K, Lage MJ.

Clin Ther. 2007 Feb;29(2):316-25.

PMID:
17472823
[PubMed - indexed for MEDLINE]
4.

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.

Cooke CE, Lee HY, Tong YP, Haines ST.

Curr Med Res Opin. 2010 Jan;26(1):231-8. doi: 10.1185/03007990903421994.

PMID:
19921965
[PubMed - indexed for MEDLINE]
5.

The impact of treatment non-compliance on mortality in people with type 1 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

J Diabetes Complications. 2013 May-Jun;27(3):219-23. doi: 10.1016/j.jdiacomp.2012.10.006. Epub 2012 Nov 13.

PMID:
23157988
[PubMed - indexed for MEDLINE]
6.

Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK.

Yurgin N, Secnik K, Lage MJ.

J Diabetes Complications. 2008 Jul-Aug;22(4):235-40. doi: 10.1016/j.jdiacomp.2006.12.001. Epub 2008 Apr 16.

PMID:
18413211
[PubMed - indexed for MEDLINE]
7.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
[PubMed - indexed for MEDLINE]
8.

All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark.

Lauritzen T, Sandbaek A, Carlsen AH, Borch-Johnsen K.

Prim Care Diabetes. 2012 Oct;6(3):193-200. doi: 10.1016/j.pcd.2012.04.005. Epub 2012 May 16.

PMID:
22595031
[PubMed - indexed for MEDLINE]
9.

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):121-7.

PMID:
12642975
[PubMed - indexed for MEDLINE]
10.

Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).

Schneider B, Martin S, Heinemann L, Lodwig V, Kolb H.

Arzneimittelforschung. 2007;57(12):762-9. doi: 10.1055/s-0031-1296677.

PMID:
18380408
[PubMed - indexed for MEDLINE]
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
12.

Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.

Bruno G, Merletti F, Boffetta P, Cavallo-Perin P, Bargero G, Gallone G, Pagano G.

Diabetologia. 1999 Mar;42(3):297-301.

PMID:
10096781
[PubMed - indexed for MEDLINE]
13.
14.

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3. Review.

PMID:
22258959
[PubMed - indexed for MEDLINE]
15.

The association between diabetes metabolic control and drug adherence in an indigent population.

Schectman JM, Nadkarni MM, Voss JD.

Diabetes Care. 2002 Jun;25(6):1015-21.

PMID:
12032108
[PubMed - indexed for MEDLINE]
16.

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.

Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA.

Diabetologia. 2006 Feb;49(2):271-8. Epub 2005 Dec 17.

PMID:
16362814
[PubMed - indexed for MEDLINE]
17.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853
[PubMed - indexed for MEDLINE]
18.

Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.

Calvert MJ, McManus RJ, Freemantle N.

Br J Gen Pract. 2007 Jun;57(539):455-60.

PMID:
17550670
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus.

Rochester CD, Leon N, Dombrowski R, Haines ST.

Am J Health Syst Pharm. 2010 Jan 1;67(1):42-8. doi: 10.2146/ajhp080706.

PMID:
20044368
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk